Abiopharma

Clinical trial NCT05338970: completion date: 2026-06-30 → 2026-12-31.

Clinical trial NCT06560853 updates: 1. completion date: 2026-11-30 → 2026-12-31 2. primary completion date: 2026-07-30 → 2026-07-15

Clinical trial NCT06158841 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 380 → 421 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06241118 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 636 → 464 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07357727: start date: 2026-06-16 → 2026-06-08.

Clinical trial NCT07117214 updates: 1. completion date: 2028-12-11 → 2029-01-26 2. primary completion date: 2028-12-11 → 2029-01-26

Clinical trial NCT05500092: collaborators added: American Cancer Society, Inc..

Clinical trial NCT06014580 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2024-10-31 3. primary completion date: 2025-12-31 → 2024-10-31

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001918704-26-025049 <b>Size:</b> 827 KB

New Form 3 - Laird Superfood, Inc. <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001437749-26-029075 <b>Size:</b> 2 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001918704-26-025050 <b>Size:</b> 566 KB

Hotchkis & Wiley Global Value Fund (HWGV) was added to the exchange traded list on NASDAQ

New Form NPORT-P - John Hancock Diversified Income Fund <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001496749-26-000014 <b>Size:</b> 773 KB

New Form NPORT-P - JOHN HANCOCK FINANCIAL OPPORTUNITIES FUND <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0000925683-26-000014 <b>Size:</b> 180 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001918704-26-025048 <b>Size:</b> 1 MB